Redox Remodeling Allows and Controls B-Cell Activation and Differentiation-Reference-Cited by-同舟云学术

Redox Remodeling Allows and Controls B-Cell Activation and Differentiation

Published:2010-10-15 Issue:8 Volume:13 Page:1145-1155
ISSN:1523-0864
Container-title:Antioxidants & Redox Signaling
language:en
Short-container-title:Antioxidants & Redox Signaling

Author:

Vené Roberta¹,Delfino Laura¹,Castellani Patrizia¹,Balza Enrica¹,Bertolotti Milena²,Sitia Roberto²,Rubartelli Anna¹

Affiliation:

1. National Cancer Research Institute, Genova, Italy.

2. Division of Genetics and Cell Biology, Università Vita-Salute-San Raffaele Scientific Institute, Milano, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry,Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry

Link

http://www.liebertpub.com/doi/pdf/10.1089/ars.2009.3078

Reference43 articles.

1. Secretion of immunoglobulin M assembly intermediates in the presence of reducing agents

2. Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation

3. The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death

4. A non-isotopic, highly sensitive, fluorimetric, cell-cell adhesion microplate assay using calcein AM-labeled lymphocytes

5. Carbon Monoxide Generated by Heme Oxygenase 1 Suppresses Endothelial Cell Apoptosis

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relationship of redox signaling with the risk for atherosclerosis;Frontiers in Pharmacology;2024-08-01

2. Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drugs;Leukemia;2024-06-14

3. The role of ROS in tumor infiltrating immune cells and cancer immunotherapy;Metabolism;2024-02

4. GLUT1-mediated glucose import in B cells is critical for anaplerotic balance and humoral immunity;Cell Reports;2024-02

5. Actives from the Micro-Immunotherapy Medicine 2LMIREG® Reduce the Expression of Cytokines and Immune-Related Markers Including Interleukin-2 and HLA-II While Modulating Oxidative Stress and Mitochondrial Function;Journal of Inflammation Research;2024-02